[1]
“Rigorous Bivariate Synthesis of Benefit-Risk Profiles for Direct Oral Anticoagulants in Atrial Fibrillation”, ST, vol. 2, no. 2, Apr. 2026, Accessed: Jun. 17, 2026. [Online]. Available: https://www.synthesis-medicine.org/index.php/journal/article/view/12